Real ‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study

Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Tags: LETTER TO THE EDITOR Source Type: research